Overview of benign and malignant lacrimal gland tumors.
Gündüz AK, Yeşiltaş YS, Shields CL.
Curr Opin Ophthalmol. 2018 Sep;29(5):458-468. doi: 10.1097/ICU.0000000000000515.
Tumors of the lacrimal gland.
von Holstein SL, Rasmussen PK, Heegaard S.
Semin Diagn Pathol. 2016 May;33(3):156-63. doi: 10.1053/j.semdp.2015.10.002. Epub 2015 Oct 9.
Carcinomas of the lacrimal drainage system.
Ramberg I, Toft PB, Heegaard S.
Surv Ophthalmol. 2020 Nov-Dec;65(6):691-707. doi: 10.1016/j.survophthal.2020.04.001. Epub 2020 Apr 15.
Malignant Mixed Tumor (Carcinoma Ex Pleomorphic Adenoma) of the Lacrimal Gland.
Tom A, Bell D, Ford JR, Debnam JM, Guo Y, Frank SJ, Esmaeli B.
Ophthalmic Plast Reconstr Surg. 2020 Sep/Oct;36(5):497-502. doi: 10.1097/IOP.0000000000001625.
Lacrimal Sac Tumors--A Review.
Krishna Y, Coupland SE.
Asia Pac J Ophthalmol (Phila). 2017 Mar-Apr;6(2):173-178. doi: 10.22608/APO.201713.
Lacrimal sac tumors.
Stefanyszyn MA, Hidayat AA, Pe'er JJ, Flanagan JC.
Ophthalmic Plast Reconstr Surg. 1994 Sep;10(3):169-84. doi: 10.1097/00002341-199409000-00005.
The spectrum of 124I uptake in the lacrimal gland and nasolacrimal sac/duct on PET/CT imaging.
Wu D, Plyku D, Kulkarni K, Garcia C, Burman KD, Wartofsky L, Van Nostrand D.
Nucl Med Commun. 2021 Mar 1;42(3):292-299. doi: 10.1097/MNM.0000000000001330.
Lacrimal gland myxoma.
Parikh D, Mukherjee B.
Indian J Ophthalmol. 2017 Sep;65(9):887-889. doi: 10.4103/ijo.IJO_226_17.
Expression profile of tumor suppressor gene RASSF1 in lacrimal gland carcinoma.
Zeng CH, Guo B, Chen J, He WM, Luo QL.
Genet Mol Res. 2015 Jun 26;14(2):6993-8. doi: 10.4238/2015.June.26.8.
Lacrimal Sac Smooth Muscle Tumor of Uncertain Malignant Potential.
Grumbine FL, DeParis SW, Vagefi MR, Bloomer M, Kersten RC.
Ophthalmic Plast Reconstr Surg. 2017 May/Jun;33(3S Suppl 1):S29-S31. doi: 10.1097/IOP.0000000000000726.
